Bleakley Financial Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.16M | Buy |
73,811
+4,050
| +6% | +$283K | 0.13% | 147 |
|
|
2025
Q1 | $5.13M | Buy |
69,761
+8,986
| +15% | +$660K | 0.16% | 122 |
|
|
2024
Q4 | $3.98M | Sell |
60,775
-5,200
| -8% | -$341K | 0.12% | 146 |
|
|
2024
Q3 | $5.14M | Buy |
65,975
+2,301
| +4% | +$179K | 0.16% | 112 |
|
|
2024
Q2 | $4.97M | Buy |
63,674
+2,817
| +5% | +$220K | 0.14% | 135 |
|
|
2024
Q1 | $4.12M | Sell |
60,857
-3,742
| -6% | -$254K | 0.12% | 168 |
|
|
2023
Q4 | $4.35M | Buy |
64,599
+4,263
| +7% | +$287K | 0.14% | 142 |
|
|
2023
Q3 | $4.09M | Sell |
60,336
-1,026
| -2% | -$69.5K | 0.14% | 129 |
|
|
2023
Q2 | $4.39M | Buy |
61,362
+1,886
| +3% | +$135K | 0.14% | 138 |
|
|
2023
Q1 | $4.13M | Buy |
59,476
+17,974
| +43% | +$1.25M | 0.14% | 139 |
|
|
2022
Q4 | $2.81M | Buy |
+41,502
| New | +$2.81M | 0.1% | 189 |
|